Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.198%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

15 Jan 2026 07:00

RNS Number : 9489O
Ashmore Group PLC
15 January 2026
 

Ashmore Group plc 15 January 2026

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc (Ashmore, the Group), the specialist Emerging Markets asset manager, announces the following update to its assets under management (AuM) in respect of the quarter ending 31 December 2025.

Assets under management

Investment theme

Actual30 September 2025

(US$ billion)

Estimated31 December 2025

(US$ billion)

- External debt

7.2

8.4

- Local currency

14.4

15.7

- Corporate debt

5.4

5.3

- Blended debt

12.1

12.5

Fixed income

39.1

41.9

Equities

7.8

8.8

Alternatives

1.8

1.8

Total

48.7

52.5

 

AuM increased by US$3.8 billion (+8%) over the period, comprising net inflows of US$2.6 billion and positive investment performance of US$1.2 billion.

Net inflows were delivered across fixed income and equities, with notable additional allocations in external debt and local currency, and new institutional mandates funding in equities and blended debt. The inflows reflect rising investor interest across the outperforming emerging markets in 2025, with allocators increasingly recognising the superior investment returns available in EM and the inherent risks of maintaining portfolios that have become heavily weighted to the US.

Emerging markets indices returned between 1% and 4% over the quarter, driven by continued economic performance, attractive valuations, stronger currencies and spread tightening.

Over the 2025 calendar year, EM fixed income indices returned between 9% and 19%, outperforming the 8% return for DM bonds, and EM equity indices increased by between 19% and 35%, comfortably outperforming the S&P500 return of 16%. Against this backdrop, Ashmore's active management continues to deliver alpha for clients across its equity and fixed income strategies.

 

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Ashmore delivered good AuM growth over the quarter with meaningful net inflows across fixed income and equities investment themes, in both global and local businesses, and continued strong investment performance for clients. It is clear that investors are acting upon the attractive risk/reward opportunities available across emerging markets and are benefiting from the continued outperformance of these markets.

"The near-term outlook for emerging countries is underpinned by continued superior economic growth compared with the developed world, relatively low or falling inflation and central banks cutting interest rates in many countries, the potential for market-friendly election outcomes in the coming year, and the benefits of a weaker US dollar. This positive environment, together with the pressure on overweight US positions, supports additional allocations to the emerging markets asset classes and an increasingly complex geopolitical situation underpins the need for active investment management to deliver outperformance."

 

Notes

Local currency AuM includes US$8.5 billion of AuM managed in overlay/liquidity strategies (30 September 2025: US$7.8 billion).

During the quarter, assets totalling US$0.1 billion were reclassified from blended debt to external debt because of changes to investment guidelines and benchmarks.

The GBP:USD exchange rate was 1.3451 as at 31 December 2025 (30 June 2025: 1.3704) and the average GBP:USD exchange rate for the first half of the financial year was 1.3393 (H1 2025: 1.2876).

Ashmore will announce its interim results in respect of the six months ending 31 December 2025 on 12 February 2026.

 

For further information please contact:

Ashmore Group plc Paul Measday +44 (0)20 3077 6278Investor Relations ir@ashmoregroup.com

Cardew Group Tom Allison +44 (0)7789 998020Will Baldwin-Charles +44 (0)7834 524833 ashmore@cardewgroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDLDISLIR
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.